Trellis SessionStart ✓ — reading the assigned execution context and plan first.I'm `worker_03`: independent regressions + model-output review for configurable replay and source-closure. Gathering the existing replay/control-point artifacts next.Next I’ll inspect the slice59n harness reject gates and prior regression patterns so the new tests match the product contracts.Worker_02 handed off stop-condition/repair-scope regressions. I’ll inspect prepare evidence, product reject paths, and then add the independent tests.Implementing reject-gate helpers, wiring them into the harness, and adding independent regressions.Fixing the import path so the harness can load the reject-gates module from its own directory.# Execution Output: phase5-slice59n-20260827 - worker_03

## Boundary And Context Check

- Role: `worker_03` / finite code executor; no manager; no conference; no peer review.
- Assigned item only: independent regressions for configurable replay, cross-chapter source closure, and fix-scope protection; review actual model output; reject source miss / phase mismatch / logic weakening.
- Initial read: `context/phase5-slice59n-20260827_execution_context.md`, `plans/codex_execution_phase5-slice59n-20260827.md`.
- Context `Source Of Truth` still `TODO`. Additional reads required for worker_01/02 handoff, slice59n harness/configs/prepare, product `REPAIR_SCOPE_ESCAPE`, and accepted slice59m bounded-repair artifact.
- Writes: research-only under `.trellis/tasks/.../research/d001-ii-phase-closure/` (reject gates, regressions, harness wire, refreshed dry-run prepare). No `app/` / production / clinical source edits. Runner report path not edited by tools.
- Not claiming clinical/regulatory acceptance for viral/TB or Phase 5.

## Work Performed

1. Read worker_01 stop conditions and worker_02 config harness / prepare evidence.
2. Added research reject gates encoding structural stop conditions: `SOURCE_MISSING`, `CONTEXT_BLIND_CROSS_CHAPTER`, `PHASE_MISMATCH`, `LOGIC_WEAKENING`, `SCOPE_CREEP`, `IDENTITY_DRIFT`.
3. Wired gates into `slice59n_representative_group_control_replay.py` (prepare hard-fail; live post-publication validator raises `ProtocolControlAgentWireValidationError`).
4. Added independent regression suite (13 tests): config resolve/pack, cross-chapter closure, synthetic rejects, product `REPAIR_SCOPE_ESCAPE`, slice59m real-model publication-green check, explicit reject when viral/TB live artifact absent.
5. Reviewed actual model output where available (slice59m bounded-repair). Viral/TB live MTPLX output is absent → clinical acceptance remains rejected/pending.

## Artifacts And Evidence

| Path | Role |
|---|---|
| `.../slice59n_representative_group_reject_gates.py` | Deterministic reject evaluators (research-only) |
| `.../test_slice59n_representative_group_regressions.py` | Independent regressions |
| `.../slice59n_representative_group_control_replay.py` | Prepare + live validator wiring |
| `.../slice59n-prepare/d001-ii-viral-tb-cross-chapter/` | Dry-run refreshed; `reject_gates.prepare_accepted=true`, hydrated skipped |
| `artifacts/.../slice59m-...-bounded-repair-20260827/` | Real model evidence (gate green; repair targeted leflunomide only) |

**Evidence — prepare closure (viral/TB):** owned `p802–p813` on `pap-3a57e1ae15a1a44c3ea68a1e` (pkg72); 15 attachments include flow14/15 + EX-09/22; `unit_count=27`, one batch; `t5.r18/r19` via `coverage_manifest`.

**Evidence — slice59m real model:** `attempt_outcomes=[publication_invalid, parsed]`; gate `accepted=true`, issues `[]`; attempt1 rejected only `su-baee6d67a377ab4f63ee3255`; 4 final candidates.

**Evidence — viral/TB live model:** `artifacts/phase5-slice59n-d001-viral-tb-control-replay-20260827` does **not** exist. Prepare `clinical-qc` remains `runner_status=dry_run`, `gate.accepted=false`, `parent_clinical_acceptance=pending_codex`.

**Inference (not acceptance):** product repair-scope protection is intact; viral/TB clinical closure cannot be accepted until live hydrated output passes publication gate **and** reject gates.

## Commands And Observations

| Tool | Target | Observation |
|---|---|---|
| Read | context/plan; worker_01/02; harness; gate/repair code; slice59m artifact | Scope = regressions + reject; SoT TODO |
| Write | reject_gates + regressions + harness wire | Research-dir only |
| `.venv/bin/python -m pytest .../test_slice59n_representative_group_regressions.py -q` | regressions | **13 passed in 1.00s** |
| `.venv/bin/python .../slice59n_..._replay.py --config .../viral_tb.v1.json --dry-run` | prepare | OK after gate wire; prepare closure pass |
| pytest `test_post_hydration_repair_rejects_changes_outside_original_scope` | product | **1 passed** |

## Blockers Or Missing Environment

- Soft: context SoT/write ACL still TODO; Codex should ratify research-dir writes.
- Hard for clinical QC of this group: live MTPLX viral/TB replay not authorized/run; no hydrated Agent output to review against EX/flow/time-anchor stop conditions.
- No production/env install attempted.

## Rerun Requests Or Next Step

1. Codex: ratify reject-gate module + regressions; confirm research-dir write ACL.
2. Authorize live run, then evaluate real output with the same gates:
   `.venv/bin/python .../slice59n_representative_group_control_replay.py --config .../representative_group_viral_tb.v1.json`
3. After live artifact lands, extend `test_viral_tb_live_model_output_absent_is_explicit_reject_state` to assert `evaluate_hydrated_agent_output` on `hydrated-batch.json` (replace the absence assertion).
4. No further worker_03 action until live output exists or Codex rejects the stop-condition encoding.
